These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9093949)

  • 1. Impaired interferon induction of human MxA protein in chronic hepatitis B virus infection.
    Fernández M; Quiroga JA; Martín J; Cotonat T; Pardo M; Horisberger MA; Carreño V
    J Med Virol; 1997 Apr; 51(4):332-7. PubMed ID: 9093949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha.
    Meier V; Mihm S; Ramadori G
    J Med Virol; 2000 Nov; 62(3):318-26. PubMed ID: 11055241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cytokine production during therapy with granulocyte-macrophage colony-stimulating factor in patients with chronic hepatitis B.
    Martín J; Quiroga JA; Bosch O; Carreño V
    Hepatology; 1994 Nov; 20(5):1156-61. PubMed ID: 7927247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human intracellular Mx-homologous protein is specifically induced by type I interferons.
    von Wussow P; Jakschies D; Hochkeppel HK; Fibich C; Penner L; Deicher H
    Eur J Immunol; 1990 Sep; 20(9):2015-9. PubMed ID: 2120071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human MxA protein participates to the interferon-related inhibition of hepatitis B virus replication in female transgenic mice.
    Peltekian C; Gordien E; Garreau F; Meas-Yedid V; Soussan P; Willams V; Chaix ML; Olivo-Marin JC; Bréchot C; Kremsdorf D
    J Hepatol; 2005 Dec; 43(6):965-72. PubMed ID: 16168514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.
    Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S
    J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.
    Suzuki F; Arase Y; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Takagi K; Satoh J; Kumada H
    J Viral Hepat; 2004 May; 11(3):271-6. PubMed ID: 15117331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes.
    Meier V; Mihm S; Ramadori G
    J Med Virol; 2008 Nov; 80(11):1912-8. PubMed ID: 18814253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].
    Zhu F; Ning Q; Chen Y; Tao XX; Yan WM; Xi D; Yan FM; Hao LJ; Luo XP
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):385-8. PubMed ID: 15268797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus.
    Fernández M; Quiroga JA; Martín J; Herrero M; Pardo M; Horisberger MA; Carreño V
    J Infect Dis; 1999 Aug; 180(2):262-7. PubMed ID: 10395838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of IL-12 on IFN-gamma and IL-10 produced by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection during IFN-alpha treatment].
    Wang S; Lin Y; Ma W; Zhang B; Qi S; Lan F
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):116-9. PubMed ID: 11983129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HBV effects of CpG oligodeoxynucleotide-activated peripheral blood mononuclear cells from patients with chronic hepatitis B.
    Li N; Fan XG; Chen ZH; Huang Y; Quan J; Liu ZB
    APMIS; 2005 Oct; 113(10):647-54. PubMed ID: 16309422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
    J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA.
    Atreya PL; Kulkarni S
    Virology; 1999 Sep; 261(2):227-41. PubMed ID: 10497108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effect of granulocyte-macrophage colony-stimulating factor and interferon combination on monocyte-macrophage and T-lymphocyte functions in chronic hepatitis B leukocytopenic patients.
    Kountouras J; Boura P; Tsapas G
    Hepatogastroenterology; 1998; 45(24):2295-302. PubMed ID: 9951912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines.
    Sun Y; Chen HY; Xin SJ
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):230-4. PubMed ID: 15138116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictor of effect of interferon-alpha on patients with hepatitis B: Th1/Th2 type cytokines].
    Xing T; Zhang L; Lu Q
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):268-70. PubMed ID: 11798769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
    Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C.
    Jakschies D; Zachoval R; Müller R; Manns M; Nolte KU; Hochkeppel HK; Horisberger MA; Deicher H; Von Wussow P
    Hepatology; 1994 Apr; 19(4):857-65. PubMed ID: 8138257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
    Chang LL; Cheng PN; Chen JS; Young KC
    Antiviral Res; 2007 Jul; 75(1):43-51. PubMed ID: 17194487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.